KQ Labs opens accelerator programme and announces LifeArc as a strategic partner

KQ Labs is now accepting applications for its third cohort of companies. Early stage data-driven health companies…

LifeArc backs 15 patient studies into ‘re-purposed’ therapies to fight coronavirus

£10m in grants mean patient enrolment can begin immediately

LifeArc and MRC partnership creates new £16m fund to establish Gene Therapy Innovation Hubs

Hubs aim to address challenges in progressing novel gene therapy research into early stage clinical trials

LifeArc provides £2m to the University of Edinburgh STOPCOVID initiative

LifeArc provides £2m to the STOPCOVID project, which aims to test existing and experimental drugs to find a treatment for COVID-19

LifeArc launches £10 million research fund to address the challenges of COVID-19

Today, LifeArc, a UK-based medical research charity, has created a £10 million fund to support research to…

LifeArc announces seed fund investment in start-up GyreOx

The funding will support a two-year programme to develop and automate GyreOx’s proprietary drug discovery platform, MACRO.

LifeArc boosts investment in Cambridge University spin-out PolyProx Therapeutics to advance new class of cancer medicines

The investment will help advance studies to validate polyproxin® molecules as potential drug candidates across a range of cancers.

LifeArc and Scottish Government Chief Scientist Office launch new funding scheme to boost translational research in Scotland

Funding aims to progress strong discovery science to a point where additional substantive funding could be secured.

LifeArc marks Rare Disease Day 2020 with a call for more translational research

Translational research can turn promising science into new treatments for those with rare diseases. It’s why we…